Charles A Herzog
Overview
Explore the profile of Charles A Herzog including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
213
Citations
6900
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Truyen T, Uy-Evanado A, Holmstrom L, Reinier K, Chugh H, Jui J, et al.
Kidney360
. 2025 Jan;
PMID: 39823188
Background: Individuals with end-stage renal disease may be at increased risk of sudden cardiac arrest (SCA) associated with dialysis therapy. However, community-based studies with comprehensive adjudication of SCA are lacking....
2.
Charytan D, Winkelmayer W, Granger C, Middleton J, Herzog C, Chertow G, et al.
Kidney Int
. 2024 Nov;
107(1):169-179.
PMID: 39490411
The optimal approach towards managing serum potassium (sK) and hemodialysate potassium concentrations is uncertain. To study this, adults receiving hemodialysis for three months or more with hyperkalemia (pre-dialysis sK 5.1-6.5...
3.
Pitt B, Agarwal R, Anker S, Rossing P, Ruilope L, Herzog C, et al.
Eur Heart J Cardiovasc Pharmacother
. 2024 Oct;
11(1):10-19.
PMID: 39380152
Aims: Hypokalaemia is associated with cardiovascular events and mortality in patients with chronic kidney disease (CKD). This exploratory FIDELITY analysis, a prespecified pooled patient-dataset from FIDELIO-DKD and FIGARO-DKD, investigated the...
4.
Wang W, Reyes J, Oyenuga A, Eaton A, Norby F, Parikh R, et al.
Mayo Clin Proc Innov Qual Outcomes
. 2024 Jul;
8(4):343-355.
PMID: 38974529
Objective: To examine the association of left atrial (LA) function with incident chronic kidney disease (CKD) and assess the clinical utility of adding LA function to a CKD risk prediction...
5.
Mathew R, Rangaswami J, Abramov D, Mahalwar G, Vellanki S, Abuazzam F, et al.
Catheter Cardiovasc Interv
. 2023 Oct;
102(7):1162-1176.
PMID: 37870080
Aims: This analysis evaluates whether proportional serial cardiac troponin (cTn) change predicts benefit from an early versus delayed invasive, or conservative treatment strategies across kidney function in non-ST-elevation acute coronary...
6.
Murphy D, Firoozi S, Herzog C, Banerjee D
Am J Cardiol
. 2023 Aug;
204:383-391.
PMID: 37579521
Cardiac troponins (cTn) are routinely measured for the diagnosis and prognosis of myocardial infarction (MI). The relation between troponin levels, estimated glomerular filtration rate (eGFR), postinfarction heart failure (HF), and...
7.
Rafique Z, Budden J, Quinn C, Duanmu Y, Safdar B, Bischof J, et al.
BMJ Open
. 2023 Jun;
13(6):e071311.
PMID: 37308268
Introduction: Hyperkalaemia is common, life-threatening and often requires emergency department (ED) management; however, no standardised ED treatment protocol exists. Common treatments transiently reducing serum potassium (K) (including albuterol, glucose and...
8.
OLone E, Apple F, Burton J, Caskey F, Craig J, deFilippi C, et al.
Kidney Int
. 2023 Apr;
103(6):1028-1037.
PMID: 37023851
Cardiovascular disease is the leading cause of death in patients receiving hemodialysis. Currently, there is no standardized definition of myocardial infarction (MI) for patients receiving hemodialysis. Through an international consensus...
9.
Gjyriqi G, York M, Abuazzam F, Herzog C, Bangalore S, Lo K, et al.
J Card Fail
. 2022 Dec;
29(3):258-268.
PMID: 36516938
Background: A substantial proportion of patients with heart failure and kidney disease have poorly controlled blood pressures. This study aimed to evaluate patterns of blood pressure after initiation of an...
10.
Reyes J, Herzog C, Yan H, Roetker N, Wetmore J
J Cardiovasc Pharmacol Ther
. 2022 Dec;
27:10742484221142220.
PMID: 36472155
Background: The association of patient and prescriber characteristics with use of warfarin versus direct-acting oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) and chronic kidney disease (CKD) is not...